Clinical Outcomes of People Who Acquired HIV in Early Life
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01656564|
Recruitment Status : Recruiting
First Posted : August 3, 2012
Last Update Posted : August 6, 2020
- Long-term survival with the human immunodeficiency virus (HIV) is not well understood. Adults who were infected with HIV as children have lived with the virus for many years. However, the effect of HIV on this group of people has not been studied in depth. Researchers are interested in studying how HIV infection and the medicines used to treat it affect people who were infected early in life. They want to find out if there are any problems with how HIV-infected children grow and develop as adults, especially if they have developed heart problems. As part of this study, people with HIV will be compared with healthy volunteers.
- To study the effect of HIV infection and treatment on people who acquired HIV infection in early life.
- Individuals at least 18 years of age who acquired HIV infection in early life.
- Healthy volunteers at least 18 years of age who have no history of heart disease.
- Participants will be screened with a physical exam and medical history. They will have regular study visits about once a year for up to 10 years to collect health information.
- Blood and urine samples will be collected to look at kidney and liver function.
- X-ray scans will be used to look at bone density and the amount of fat and muscle in the body.
- Treatment will not be provided as part of this study....
|Condition or disease|
- Antiretroviral therapy (ART) has altered the natural history of HIV disease in children.
- Long-term survivors of pediatric HIV infection offer a tremendous opportunity to understand the effects of HIV and ART health outcomes.
- A thorough understanding of the impact of HIV and ART on these long-term processes is extremely relevant as ART programs for HIV-infected children expand globally.
- To explore the clinical outcomes and the impact of HIV infection and ART on a cohort with HIV infection acquired in early life
- Individuals at least 18 years of age who acquired HIV infection in early life
- Healthy volunteers without HIV (greater than or equal to 18 years of age) will serve as controls
- Annual evaluations of health status, immune function and other health parameters related to HIV infection will be conducted.
|Study Type :||Observational|
|Estimated Enrollment :||250 participants|
|Official Title:||Clinical Outcomes of Persons With HIV Acquired Early in Life (COPE)|
|Actual Study Start Date :||August 27, 2012|
Age, sex, race-matched healthy volunteers
Individuals who acquired HIV in early life
- Health Status [ Time Frame: End of Study ]vital status and health outcomes will be determined annually throughout the study
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01656564
|Contact: Julia B Purdy, C.R.N.P.||(301) firstname.lastname@example.org|
|United States, Maryland|
|National Institutes of Health Clinical Center, 9000 Rockville Pike||Recruiting|
|Bethesda, Maryland, United States, 20892|
|Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR) 800-411-1222 ext TTY8664111010 email@example.com|
|Principal Investigator:||Colleen M Hadigan, M.D.||National Institute of Allergy and Infectious Diseases (NIAID)|